Every medication Gene2Rx tests, in one report.
The Full Report is for anyone who wants the complete picture in a single place. If you take medications from more than one category, if you are not sure which drugs a future prescription might involve, or if you simply want the most thorough result Gene2Rx offers, this is the report to choose. It covers the same psychiatric medications as the Psychiatric Report and adds every other therapeutic area we have guidance for, so nothing is left out.
The Full Report analyzes every drug in the Gene2Rx guideline set, spanning all of the therapeutic classes listed below. For each medication it draws together the published pharmacogenetic guidance from the FDA, [1] the Clinical Pharmacogenetics Implementation Consortium (CPIC), [2] the Dutch Pharmacogenetics Working Group (DPWG), [3] and Gene2Rx's own curation where a well supported gene-drug relationship has not yet been formally written up.
The Full Report is the most complete tier, so it excludes no drug category that a narrower report would cover. It is still bounded by the science: it reports only on genes and drugs that have published pharmacogenetic guidance, so a medication with no established gene-drug link will not appear. It is generated from the genotype data you upload. A consumer array reads a fixed set of positions, so some structural variants, most notably CYP2D6 gene deletions and duplications, cannot be called reliably from array data and are noted rather than assumed. The report is informational and is not a diagnostic test or a substitute for advice from your prescriber.
Nothing is left out. The Full Report is the most complete tier and covers every medication Gene2Rx tests, across all 33 drug classes above.
Each drug is grouped by the gene that matters most for it, and your result is expressed as a metabolizer or function phenotype, for example a CYP2C19 rapid metabolizer or a CYP2D6 poor metabolizer. Alongside the phenotype the report gives the recommendation from each source and an evidence strength of Strong, Moderate, or Optional so you can weigh how firm the guidance is. Gene2Rx accepts genotype data on either the GRCh37 or GRCh38 genome build. Nothing in the report tells you to start, stop, or change a medication on its own. Bring it to the clinician who manages your prescriptions and use it as a starting point for that conversation.
$49 from a single genetic data upload. Whole Genome Sequencing VCFs add $15 per report.
Buy Now See example reportInformational only, not medical advice. Gene2Rx uses genotype data you upload and reports only on genes and drugs with published pharmacogenetic guidance. Consumer arrays cannot reliably call some structural variants, such as CYP2D6 gene deletions and duplications. Never start, stop, or change a medication without talking to your prescribing clinician.